Publications by authors named "Pia Ipsen"

Objectives: To evaluate diagnostic accuracy of F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) compared to contrast-enhanced CT in assessment of inguinal lymph node (ILN) metastases, distant metastases and synchronous cancers in patients with penile squamous cell carcinoma (pSCC).

Patients And Methods: During a 4-year period, patients with pSCC were scheduled for FDG PET/CT prior to surgical treatment at two referral centres that manage all penile cancers in Denmark. The primary endpoint was diagnostic accuracy of FDG PET/CT and of CT alone with histopathology or Response Evaluation Criteria In Solid Tumors (RECIST) as reference.

View Article and Find Full Text PDF

Background: Preoperative staging with F-fluorodeoxyglucose (F-FDG) positron emission tomography (PET) combined with computed tomography (CT) is used for the evaluation of metastatic disease in patients with invasive bladder cancer. The use of quantification with maximum standardized uptake value (SUVmax) of regional lymph nodes (LNs) has been suggested to increase the diagnostic ability for detection of malignancy.

Objective: Assessment of the utility and clinical relevance of SUVmax in F-FDG PET in detecting regional nodal metastases in patients considered for radical cystectomy.

View Article and Find Full Text PDF

F-FDG PET/CT performed for primary staging 3 days after ureteroscopy demonstrated a large, unexpected retroperitoneal urinoma in a 62-year-old man with urothelial carcinoma in the right renal pelvis.

View Article and Find Full Text PDF

Objectives: To estimate the diagnostic accuracy of sentinel node biopsy (SNB) combined with preoperative (18) F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for inguinal lymph node (LN) evaluation in patients with invasive penile squamous cell carcinoma (PSCC) with no clinical evidence of inguinal metastases (cN0) at two tertiary centres with complete clinical follow-up.

Patients And Methods: From April 2010 in Centre one and from January 2013 in Centre two, we prospectively enrolled patients diagnosed with invasive PSCC and scheduled for SNB at the only two university centres treating penile cancer in Denmark. All patients had FDG PET/CT before SNB.

View Article and Find Full Text PDF